Skip to main content
. 2021 Mar 16;67(1):252–270. doi: 10.1016/j.survophthal.2021.03.003

Table 2.

Summary of most relevant works where fundus images are taken as input.

Year Reference Topic Model Dataset (patients) Output: classes AUC Sens. Spec. Better than experts? (N)
2020 Varadarajan et al. [68] DME CNN (InceptionV3) Thailand (4732) / EyePACS-DME (554) Center-involved DME 0.890 0.850 0.800 Yes (3)
Intraretinal fluid 0.810
Subretinal fluid 0.880
2020 Singh and Gorantla [71] DME CNNs (Hierarchical Ensemble of 5) Messidor (1200) / IDRiD (516) DME 0.947/ 0.979 0.972/ 0.945
DME: (three-class grading) 0.964 0.958
2019 Arsalan et al. [23] DR, Vessel seg. CNN (Custom, Vess-Net) DRIVE (40) / CHASE-DB1 (128) / STARE (20) Vessel segmentation map 0.980–0.988 0.802–0.853 0.979–0.984
2019 Sayres et al. [69] DR CNN (InceptionV4) Patients from Krause2018 (1612) DR: None, mild, moderate, severe, prolif. 0.925 0.946 Yes (10)
2019 Cao et al. [22] DR Naive Bayes on grey coocurrence matrix Private (1000) DR 0.938 0.949 0.928
2019 Yang et al. [67] DR CNN (IDx-DR) Private (500) DR: None, mild, moderate, severe, prolif. 0.988 0.880
2019 Peng et al. [70] AMD (Bilateral images) CNN (Inceptionv3: DeepSeeNet) AREDS (4549) AMD: AREDS early AMD progression risk scale (five classes) 0.590 0.930 Yes (88)
Drusen: Small / none, medium, large 0.940 0.718 0.871 Yes
Pigment. abnorm. 0.930 0.732 0.957 Yes
Late AMD 0.970 0.627/ 0.538 0.987/ 0.898 No
2019 Coyner et al. [50] ROP CNN (InceptionV3) i-ROP (898) ROP: Image quality assesment (2 classes) 0.9650 0.939 0.836 Same (6)
2019 Tan et al. [72] ROP CNN (ROP.AI) Australasian ART-ROP (500) ROP: Normal, plus-disease 0.9770 0.939 0.807
ROP: Normal, pre-plus disease 0.814 0.807
2018 Grassmann et al. [45] AMD CNN (Ensemble of six) AREDS (3654) / KORA (5555) AMD: AREDS scale (13 classes) 0.538/0.328 0.969/0.957 Yes
2018 Rajalakshmi et al. [73] DR (Phone images) CNN (EyeArt) Private (296) DR grade: Any, DME, prolif., referrable 0.781–0.993 0.688–0.898
2018 Kanagasingam et al. [74] DR CNN (IDx-DR) Private (193) DR: None, mild, moderate, severe, prolif. 0.920
2018 Krause et al. [36] DR CNN (InceptionV4) EyePACS (242252) DR: None, mild, moderate, severe, prolif. 0.986 0.970 0.917 Same (6)
2018 Brown et al. [52] ROP CNN (Vessel seg.: U-Net) + CNN (Classif.: InceptionV1) i-ROP (898) ROP 0.940 0.930 0.940 Yes (8)
ROP: Plus disease 0.980 1,000 0.940
2018 Wang et al. [51] ROP CNN (custom, Inception-like) Chengdu Women Children's Central Hospital (1273) ROP 0.849 0.969 Same (3)
ROP: Minor, severe 0,736 0,933
2017 Li et al. [16] Glaucoma CNN (InceptionV3) Guangdong (3970) Glaucoma: Referable, nonreferable 0.986 0.956 0.920
2017 Gargeya and Leng [34] DR CNN (Custom) + Decission tree (Grad. Boosting) EyePACS (15000) / Messidor-2 (874) / E-Optha (100) DR: Referable, Non Referable 0.940–0.970 0.900–0.940 0.870–0.980
2017 Ting et al. [39] DR CNN (VGG-19) SIDRP 10-15 (27979) / Guangdong (3970) + 9 others DR: Referable, non referable 0.889-0.983 0.905-1.000 0.733-0.916
Glaucoma SIDRP 10-15 (27979) + 5 others Glaucoma: Referable, non referable 0.942 0.964 0.872
AMD Idem AMD: Referable, non referable 0.931 0.932 0.887
2017 Burlina et al. [2] AMD CNN (AlexNet) AREDS (4613) AMD 0.940 0.846 0.920 Same
2016 Abràmoff et al. [75] DR CNN (IDx-DR vX2.1) Messidor-2 (874) DR: None or mild, present, vision-threatening 0.980 0.968 0.870
2016 Gulshan et al. [3] DR, DME CNN (InceptionV3) EyePACS (4997) / Messidor-2 (874) DR: Referable, non referable 0.991/ 0.990 0.903/ 0.870 0.981/ 0.985
DME: Referable, non referable 0.974 0.907 0.938
2012 Zheng et al. [44] AMD Hierarchical trees + SVM ARIA (161) / STARE (97) AMD 0.994 1,000
2011 Agurto et al. [8] AMD, DR (3 FOV fundus) Feature extraction + Partial Least Squares RIST (378) / UTHSCSA (444) DR: Normal, sight-threatening 0.890/ 0.920 0.950 0.500
DR-related: Microaneurysms, hemorrhages, exudates, neovascularization, etc. 0.770-0.980 0.830–1.00 0.500
AMD-related: Drusen, Pigment. abnorm., GA 0.770-0.920 0.88–1.000 0.500